Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study

BACKGROUND: Neurofilament light (NFL) has been increasingly recognized for prognostic and therapeutic decisions. OBJECTIVE: To validate the utility of cerebrospinal fluid NFL (cNFL) as a biomarker in clinical practice of relapsing-remitting multiple sclerosis (RRMS). METHODS: RRMS patients (n = 757)...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstein, Igal, Axelsson, Markus, Novakova, Lenka, Blennow, Kaj, Zetterberg, Henrik, Lycke, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024026/
https://www.ncbi.nlm.nih.gov/pubmed/34392718
http://dx.doi.org/10.1177/13524585211039104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024026/
https://www.ncbi.nlm.nih.gov/pubmed/34392718
http://dx.doi.org/10.1177/13524585211039104

Ejemplares similares